COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.covid19.nih.gov/

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

The Microbial Diagnostics and Detection of Infectious Agents, Food and Waterborne Pathogens, and Methods in Microbial Sterilization, Disinfection, and Bioremediation (AIDC (13)) study section reviews small business (SBIR/STTR) applications that focus on the development of microbial detection, quantitation, and diagnostics; detection of food and waterborne pathogens, and development of technologies to advance areas of microbial sterilization, disinfection, and bioremediation.

Review Dates

Topics


  • Technological and/or conceptual innovations for the detection or quantitation of bacteria, viruses (including HIV), eukaryotic pathogens, and prions.
  • Novel platforms (molecular or immunological assays/devices) for simultaneous detection of pathogens and, antimicrobial drug susceptibility and resistance
  • Point-of-care, point-of-need, and point-of-use microbial detection and quantitation systems for Physician’s office and resource-challenged settings
  • Development of novel agents or methods to detect and quantitate pathogens embedded within biofilms in vivo and on medical devices
  • Detection and quantitation of pathogens and toxins of microbial origin in food or drinking water
  • Advances in sterilization, decontamination or disinfection technologies
  • Development of novel applications for microbial bioremediation

Shared Interests and Overlaps:

There are shared interests with Anti-Infective Therapeutics [AIDC (12)] in the area of microbiology of infectious agents. Small business applications that seek to develop antibiotic agents that include effectiveness in the context of biofilms may be reviewed in AIDC (12). Applications addressing the development of agents or methods to detect or combat biofilms in vivo and on medical devices may be reviewed here.

There are shared interests with Innovative Immunology [AIDC (10)] in the area of microbiology of infectious agents. Small business applications that seek to develop diagnostic immunoassays and immunological markers for the detection of microbial pathogens may be reviewed in AIDC (10). Applications that focus on the microbial pathogen while using immunological methods may be reviewed here.

There are shared interests with Biological Chemistry, Biophysics, and Assay Development [IMST (10)] in the area of microbiology of infectious agents. Small business applications that address technological advances for biophysical measurements, high-throughput methods, or molecular screens as related to microbial diagnostics or quantification may be reviewed in IMST (10), whereas applications that focus on the microbial pathogen in the context of diagnostics or quantification may be reviewed here.

There are shared interests with Instrumentation, Environmental, and Occupational Safety [IMST (12)] in the area of microbiology of infectious agents. Small business applications that address chemical, optical, electronic, spectroscopic or microscopic technologies that are applied to microbial environmental monitoring or portable point-of-care devices may be reviewed in IMST (12). Applications that focus on the microbial pathogen in the context of environmental monitoring or point-of-care devices may be reviewed here.

There are shared interests with Computational, Modeling, and Biodata Management [IMST (14)] in the area of microbiology of infectious agents. Small business applications that advance bioinformatics, computational and modeling technologies as related to microbial detection and quantification may be reviewed in IMST (14), whereas applications that focus on the microbial pathogen in the context of using existing technologies may be reviewed here.